incretin glp 1 Targeting both receptors together for a new generation of diabetes therapies Incretin-based therapy of metabolic disease

First clinical trial to investigate the efficacy and safety of combined SGLT2 inhibitor and GLP-1R agonist therapy in patients with T2DM, suggesting additive or synergistic effects on weight loss

Besides improving skin complexion and whitening, it minimizes pores and suppresses acne, blemish, and pimples formation

Side effects are rare and typically mild, such as slight discomfort at the injection site or temporary bruising

It is available as a liquid solution in prefilled injection pens

The compound is in phase-2 clinical trials as a potential therapy for children with GHD [9]

Puerarin Puerarin is a crown-expanding isoflavone derivative separated from the roots of Pueraria lobata (Willd) Ohwi and Pueraria thunbergiana Benth